Comparative Evaluation of Two Commercial Multiplex Panels for Detection of Gastrointestinal Pathogens by Use of Clinical Stool Specimens
- 1 October 2014
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (10), 3667-3673
- https://doi.org/10.1128/jcm.01637-14
Abstract
The detection of pathogens associated with gastrointestinal disease may be important in certain patient populations, such as immunocompromised hosts, the critically ill, or individuals with prolonged disease that is refractory to treatment. In this study, we evaluated two commercially available multiplex panels (the FilmArray gastrointestinal [GI] panel [BioFire Diagnostics, Salt Lake City, UT] and the Luminex xTag gastrointestinal pathogen panel [GPP] [Luminex Corporation, Toronto, Canada]) using Cary-Blair stool samples ( n = 500) submitted to our laboratory for routine GI testing (e.g., culture, antigen testing, microscopy, and individual real-time PCR). At the time of this study, the prototype (non-FDA-cleared) FilmArray GI panel targeted 23 pathogens (14 bacterial, 5 viral, and 4 parasitic), and testing of 200 μl of Cary-Blair stool was recommended. In contrast, the Luminex GPP assay was FDA cleared for the detection of 11 pathogens (7 bacterial, 2 viral, and 2 parasitic), but had the capacity to identify 4 additional pathogens using a research-use-only protocol. Importantly, the Luminex assay was FDA cleared for 100 μl raw stool; however, 100 μl Cary-Blair stool was tested by the Luminex assay in this study. Among 230 prospectively collected samples, routine testing was positive for one or more GI pathogens in 19 (8.3%) samples, compared to 76 (33.0%) by the FilmArray and 69 (30.3%) by the Luminex assay. Clostridium difficile (12.6 to 13.9% prevalence) and norovirus genogroup I (GI)/GII (5.7 to 13.9% prevalence) were two of the pathogens most commonly detected by both assays among prospective samples. Sapovirus was also commonly detected (5.7% positive rate) by the FilmArray assay. Among 270 additional previously characterized samples, both multiplex panels demonstrated high sensitivity (>90%) for the majority of targets, with the exception of several pathogens, notably Aeromonas sp. (23.8%) by FilmArray and Yersinia enterocolitica (48.1%) by the Luminex assay. Interestingly, the FilmArray and Luminex panels identified mixed infections in 21.1% and 13.0% of positive prospective samples, respectively, compared to only 8.3% by routine methods.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of Luminex xTAG Gastrointestinal Pathogen Analyte-Specific Reagents for High-Throughput, Simultaneous Detection of Bacteria, Viruses, and Parasites of Clinical and Public Health ImportanceJournal of Clinical Microbiology, 2013
- Antibacterial prescriptions for acute gastrointestinal infections: uncovering the icebergEpidemiology and Infection, 2012
- Real-Time Qualitative PCR for 57 Human Adenovirus Types from Multiple Specimen SourcesJournal of Clinical Microbiology, 2012
- Comparison of Two Commercial Molecular Assays to a Laboratory-Developed Molecular Assay for Diagnosis of Clostridium difficile InfectionJournal of Clinical Microbiology, 2011
- Foodborne Illness Acquired in the United States-Major PathogensEmerging Infectious Diseases, 2010
- Infectious diarrhea: when to test and when to treatCMAJ : Canadian Medical Association Journal, 2010
- Three-Hour Molecular Detection of Campylobacter , Salmonella , Yersinia , and Shigella Species in Feces with Accuracy as High as That of CultureJournal of Clinical Microbiology, 2010
- Emerging infections of the gastrointestinal tractBest Practice & Research Clinical Gastroenterology, 2009
- Enteric infections, diarrhea, and their impact on function and developmentJCI Insight, 2008
- Use of TaqMan Real-Time Reverse Transcription-PCR for Rapid Detection, Quantification, and Typing of NorovirusJournal of Clinical Microbiology, 2006